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Abstract 27 
Polyphenols form a group of important natural bioactive compounds with numerous ascribed health-beneficial 28 
attributes (e.g. antioxidant, anti-inflammatory, anti-microbial and tumor-suppressing properties). Some polyphenols 29 
can also be used as natural dyes or plastic precursors. Notwithstanding their relevance, production of most of these 30 
compounds still relies on extraction from plant material, which for most of it is a costly and an inefficient procedure. 31 
The use of microbial cell factories for this purpose is an emerging alternative that could allow a more efficient and 32 
sustainable production. The most recent advances in molecular biology and genetic engineering, combined with the 33 
ever-growing understanding of microbial physiology have led to multiple success stories. Production of multiple 34 
polyphenolic compounds or their direct precursors has been achieved not only in the common production hosts, such 35 
as Escherichia coli and Saccharomyces cerevisiae, but also in Corynebacterium glutamicum and Lactococcus lactis. 36 
However, boosting production of native compounds or introduction of heterologous biosynthetic pathways also 37 
brings certain challenges, such as the need to express, balance and maintain efficient precursor supply. This review 38 
will discuss the most recent advances in the field of metabolic engineering of microorganisms for polyphenol 39 
biosynthesis and its future perspectives, as well as outlines their potential health benefits and current production 40 
methods. 41 
  42 
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Introduction 43 
There exist over  200,000 different secondary metabolites in plants [1, 2].  Of those, polyphenols are among the 44 
most widespread and ubiquitous classes. It has  been estimated that in some cases up to 20% of the fixed carbon 45 
goes into the phenylpropanoid pathway that leads to the production of the majority of naturally-occurring phenolic 46 
compounds [3]. Although polyphenols are classified as secondary metabolites, i.e. molecules that in plants play little 47 
or no role in primary metabolism and therefore are not essential for cell’s survival under normal conditions, these 48 
compounds may accumulate in considerably high amounts [4]. Polyphenols perform many diverse functions in 49 
plants, including anti-microbial and anti-fungal protection, insect feeding deterrence, providing coloration to leaves, 50 
flowers, and fruits, attraction of pollinators, chelation of toxic heavy metals, protection from UV radiation-induced 51 
damage, and free radical scavenging [5–8]. 52 
In plants, the aromatic amino acids L-phenylalanine and L-tyrosine are the two biosynthetic precursors of 53 
phenylpropanoid compounds (Fig. (1)), [9]). This group consists of compounds with the C6-C3 backbone, such as 54 
cinnamic acid derivatives, coumarins, and lignans [10]. This backbone can be further extended with up to three two-55 
carbon units derived from malonyl-CoA generating various polyphenols, such as curcuminoids, flavonoids, 56 
stilbenes, and styrylpyrones. Of those, the flavonoids (C6-C3-C6 backbone) are the largest group. The vast chemical 57 
diversity of flavonoids arises from differences in the backbone structure, as well as from a variety of modifications 58 
to the backbone. Possible modifications are acetylation, aryl-migrations, glycosylations, hydroxylations, 59 
methylations, polymerizations, and prenylations. Based on these variations, the flavonoids can be further subdivided 60 
into aurones, flavanones, flavones, isoflavones, flavonols, flavan-3-ols, anthocyanidins, and tannins (Fig. (1)), [10]). 61 
A good example of the diversity of the decorations is provided by the anthocyanins, most of which are 62 
anthocyanidins glycosylated at the position 3 of the C-ring. Anthocyanins may have additional functional groups 63 
such as glycosyl groups (e.g. 5-glycosylation and 3’-glycosylation), methyl groups (e.g. 3′-methylated petunidin and 64 
7, 3’-methylated rosinidin), hydroxyl groups (which distinguish pelargonidin, cyanidin, and delphinidin derivatives), 65 
and acyl groups (on glycosyl moieties, could be both aromatic and/or aliphatic). These decorations can profoundly 66 
affect chemical properties such as color, hydrophobicity, and stability, as well as have a strong impact on the 67 
compounds bioavailability and bioactivity [11–14]. 68 
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Polyphenols exhibit an immense natural chemical diversity and appear to have a number of different molecular 69 
targets, participating in several signaling pathways, and exhibiting pleiotropic activities both in plants and inside the 70 
human body when taken up as a part of diet [13, 15–20]. In addition, their occurrence in plants as complex mixtures 71 
makes it possible to take advantage of additive or synergistic activities of such combinations [21–23]. As a result of 72 
their diversity in structure and the ethnic knowledge of the use of particular plants in traditional medicine [24, 25], 73 
polyphenols have been the subject of intense research with respect to their health benefits [26–28]. Along with their 74 
use as pharmaceuticals, polyphenols have found many other potential applications such as natural pigments and food 75 
colorants, preservatives, monomers for bioplastics and composites, etc. [29–32]. 76 
In  recent years the global market for polyphenols has seen continuous growth, with the main booster being the 77 
accumulated evidence of polyphenols’ health-promoting traits leading to increased sales of polyphenols-containing 78 
food supplements, cosmetics, and other type of pharma- and nutraceutical products [33, 34]. In order to keep up with 79 
the increasing demand, there is a need for innovative solutions to the large-scale production of such compounds that 80 
can replace the less economic and eco-friendly traditional production methods, such as direct purification from plant 81 
raw materials or chemical synthesis. In this scenario, bio-based production of chemicals through metabolic 82 
engineering of microorganisms has emerged as a viable, affordable, and sustainable alternative. The advent of 83 
functional “Omics”, genome-scale modeling, and high-throughput screening technologies, combined with the ever-84 
growing genome engineering, editing, and  (heterologous) gene expression toolbox, has brought metabolic 85 
engineering to a more systematic and global level, thus significantly reducing the costs associated with the complete 86 
development of a novel bioprocess. The variety and complexity of chemicals that can now be produced using 87 
microbial cell factories has remarkably increased allowing now even the production of complex polyphenols with 88 
multiple biosynthetic pathways steps [35, 36]. 89 
This review will first focus on health benefits of different polyphenol groups and their applications. The current 90 
extraction and production approaches will then be discussed. Lastly, the ongoing research towards development of 91 
alternative production methods with a special emphasis on harnessing the potential of microbes as cell factories for 92 
the biosynthesis of polyphenols will be covered. 93 
 94 
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Polyphenols, their health-beneficial effects, and potential applications 95 
 96 
Although primarily known as anti-oxidants, polyphenols possess multiple other health-beneficial properties. Most 97 
notably, there are several studies that recommend daily intake of high levels of polyphenols as a mean of reducing 98 
risks of cardiovascular disorders and type II diabetes [37–39]. Furthermore, these compounds were demonstrated to 99 
have an effect on certain types of cancer, neurodegenerative diseases, allergies, inflammation, and also to alleviate 100 
menopausal symptoms by estrogen mimicking [16, 40–44]. Additionally, polyphenols were documented to have 101 
anti-inflammatory, anti-aging, anti-angiogenic properties, as well as anti-viral and antimicrobial activities against 102 
human pathogens [45–50]. An overview of the specific health-promoting properties of the major groups of 103 
polyphenols is given in Table 1. 104 
 105 
Bioactivities of polyphenols extend beyond the field of pharmaceutics, and these compounds are also known for 106 
their many applications in food and cosmetics industries as natural substituents for synthetic ingredients. The 107 
concern over the safety of synthetic colorants raised by consumer groups [51, 52], combined with the health benefits 108 
provided by the many naturally-occurring pigments, has triggered the current marketing trend for replacement of 109 
artificial food dyes with natural colors [53]. In this respect, the bright and diverse colors of anthocyanins (hue range 110 
from red to bluish-red to purple), together with their health-beneficial properties, relative stability, and high 111 
solubility in water, make these flavonoids excellent candidates for food applications (Table 1) [12, 54–56]. As 112 
multiple anthocyanins are approved by the European Food Safety Authority [57], a great demand for their use as 113 
potential substitutes for the banned synthetic dyes is expected [58–60]. Similarly to colorants, the search for natural 114 
solutions to replace currently-used preservatives is also ongoing. Processed foods with minimal synthetic additives 115 
and thermal treatment are becoming an increasing trend. Thus, innovative solutions to extend product shelf-life, 116 
such as the use  of natural preservatives, are required [61, 62]. The antimicrobial activity of flavonoids is a general 117 
attribute of this group of compounds, with some specific flavonoids also possessing anti-viral and anti-fungal 118 
properties [47, 63]. Moreover, being strong antioxidants [8, 64] flavonoids could potentially protect food from some 119 
undesirable chemical changes.  Altogether, these attributes make flavonoids a very promising new group of natural 120 
preservatives suitable for use in food industry. Cosmetics is another area of interest for polyphenol applications. 121 
Multiple plant species that are enriched in polyphenols, such as cocoa, grape, olive, and tea, are used in cosmetic 122 
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products [65–67]. The potential of the application of coffee polyphenolic extract and of caffeic acid alone as 123 
components for skin care formulations has also been studied [68, 69]. Apart from protecting skin from UV radiation 124 
and reactive oxygen species, polyphenols have several other beneficial effects, including antiaging (via inhibition of 125 
lipoxygenase, cyclooxygenase, and skin re-modeling enzymes elastase and collagenase), depigmenting (via 126 
inhibition of tyrosinase), inhibition of inflammatory responses, and anti-microbial activity [66, 70, 71]. These data 127 
provide a good foundation for further research directed towards the application of purified polyphenolic compounds 128 
(single or as mixtures) in skincare products. 129 
 130 
Current approaches/methods for the production of polyphenols 131 
 132 
At the moment all purified polyphenolic compounds available on the market are either obtained through extraction 133 
from plant sources (e.g. fruits, leaves, or roots), or by total or partial chemical synthesis. So far, resveratrol remains 134 
the only exception to these traditional production methods that is also produced by microbial synthesis using 135 
Saccharomyces cerevisiae (Table 2). The extraction procedures impose numerous limitations that hinder the 136 
exploitation of polyphenols for pharmaceutical and biotechnological applications at their full potential [72, 73]. 137 
Factors such as low natural abundance inside plant tissues, environmental and geographical conditions, seasonal 138 
variation, and the need for complex downstream processing could have a significant impact on the extraction yields 139 
of polyphenols. Consequently, the extraction procedures from plant sources are generally labor-intense, costly, and 140 
using plant sources may consume large amounts of resources, such as water and land. Furthermore, the resulting 141 
preparations tend to contain impurities. One of the best known examples is the laxative emodin that is often co-142 
purified with and contaminates resveratrol extracts from Japanese knotweed (Polygonum cuspidatum Siebold & 143 
Zucc.) [74]. Furthermore, despite all the progress made in the field of metabolic engineering of plants and plant cell 144 
factories for increased production of native secondary metabolites, their application as production hosts for 145 
polyphenols is still limited [75–79]. On the other hand, chemical synthesis of polyphenols has limited options for 146 
large-scale production due to the high structural complexity of these molecules. Both de novo synthesis and 147 
synthesis from purified precursors involves the use of hazardous and toxic chemical solvents, as well as extreme 148 
reaction conditions, thus limiting their application to specialized small-scale production [80]. Molecular chirality 149 
imposes additional challenges to chemical synthesis, as this process is not stereo-specific and yields a mixture of R- 150 
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and S-stereoisomers, whereas only 2S-stereoisomers of polyphenols were shown to be bioactive [81]. Consequently, 151 
an extra purification step is required for separating the isomers further reducing the final yield. Hence, more modern 152 
and environmentally-minded approaches are required in order to meet the growing demands for these 153 
phytochemicals. 154 
 155 
Microbial production of plant polyphenols: past achievements and ongoing research 156 
 157 
The inefficiency of traditional production methods is a major obstacle to broadening the range of applications for 158 
added-value polyphenols, and consequently successful commercialization would require implementation of large-159 
scale, cost-effective, and sustainable production processes. In light of that, construction of designer microorganisms 160 
serving as biological platforms for the production of phenolic compounds is becoming a promising alternative. 161 
Industrial workhorses, such as Bacillus subtilis, Escherichia coli or Saccharomyces cerevisiae, have been used for 162 
decades in numerous bioprocesses, including biological production of compounds with applications in 163 
pharmaceutical, food, and chemical industries.  Microbial production of fine chemicals presents multiple advantages 164 
that have been reviewed previously [82–84]. Briefly, as compared to plants and plant cell cultures, the 165 
microorganisms that are used for production are usually fast-growing and easy to cultivate, which greatly reduces 166 
processes costs and production times. They are also able to grow in diverse media, including industrial and 167 
agricultural waste, which makes the bioproduction more sustainable. Moreover, microbial fermentations are readily 168 
scalable from laboratory through demonstration to commercial production scales. Also, the ease of genetic 169 
manipulation with these organisms and the availability of molecular tools (e.g. for expression of heterologous 170 
polyphenol pathway genes, for manipulation of homologous polyphenol pathway genes, or for genome editing) 171 
facilitates the construction of microbial cell factories tailored for production of nearly any natural (and even non-172 
natural) metabolite imaginable [83]. Furthermore, the use of microbial hosts for the production of polyphenols 173 
simplifies the product purification procedure, as their secondary metabolism is generally much simpler and 174 
competing pathways can be eliminated or deactivated. Lastly, as opposed to the traditional methods for obtaining 175 
natural products, microbial-based production can be a lot more environmentally-friendly, as the  use of organic 176 
solvents or other harsh chemicals for product purification can be reduced [85, 86]. Production of fine chemicals 177 
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using microorganisms also requires considerably less natural resources, such as extensive land and water usage, as 178 
well as fertilizers and pesticides, needed to obtain and process large amounts of raw plant material [87, 88].  179 
 180 
Over the past years, multiple studies demonstrated the potential of microbial cell factories for the production of 181 
diverse classes of plant natural products (reviewed in [73, 83]). Among the polyphenols, various flavonoids [35, 83], 182 
stilbenes [89], raspberry ketone, a raspberry flavor molecule [90], caffeic acid, a lignin precursor [91, 92], and 183 
curcuminoids [93, 94]  have been heterologously produced in microorganisms. The most interesting examples of 184 
polyphenol production using microbial cell factories are summarized in Table 3. There is also an example of 185 
production titers, productivity, and yield that meet the targets of the large-scale commercialization being achieved. 186 
The Swiss company Evolva is manufacturing resveratrol using yeast (S. cerevisiae) as the production platform [95]. 187 
Up to now their EveResveratrol
TM
 remains the only marketed phenolic compound produced de novo by fermentation 188 
in metabolically-engineered microorganisms (Table 2). It is also noteworthy that Evolva has either already 189 
established, or is about to initiate microbial production of several other phytochemicals, including the flavor and 190 
fragrance ingredient vanillin, the spice saffron, and the natural stevia sweeteners (http://www.evolva.com/products/). 191 
This example clearly demonstrates the feasibility of commercial bio-based production of plant-borne compounds in 192 
microbial cell factories. 193 
From early days, the health benefits ascribed to polyphenols have prompted a significant amount of research work 194 
towards the elucidation of their biosynthetic pathways, the genes involved, and their regulation. The information 195 
gathered over the past years has led to multiple cases of successful genetic and/or metabolic engineering of whole 196 
plants or of plant cell cultures for improved biosynthesis of native and non-native polyphenolic compounds (for 197 
selected reviews see [33, 75, 77, 96–99]). This section, however, will only focus on the latest developments in the 198 
field of polyphenol production by microorganisms, since these are probably the better candidates for a large-scale 199 
and sustainable production. 200 
The first steps of the phenylpropanoid biosynthesis pathway lead to the production of p-coumaric acid via 201 
deamination of the aromatic amino acids L-phenylalanine or L-tyrosine (Fig. (1)). Production of p-coumaric acid 202 
from L-phenylalanine is a two-step process where the amino acid is first converted into trans-cinnamic acid by a 203 
phenylalanine ammonia-lyase (PAL), which is further hydroxylated by cinnamate 4-hydroxylase (C4H), a 204 
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cytochrome P450 enzyme. The successful production of p-coumaric acid from L-phenylalanine was first 205 
demonstrated in S. cerevisiae by co-expression of PAL- and C4H-coding genes [100]. However, expression of this 206 
pathway in bacteria presents a challenge due to involvement of the P450 enzyme. These proteins are usually 207 
membrane-bound, thus functional expression in prokaryotes is difficult due to lack of the endoplasmic reticulum. 208 
Also, cytochromes P450 rely on P450 reductase enzymes (CPR) for cofactor regeneration, which are not present in 209 
bacteria and therefore need to be co-introduced into production strains [36]. In contrast, conversion of L-tyrosine into 210 
p-coumaric acid occurs in a single step catalyzed by a tyrosine ammonia-lyase (TAL), circumventing the need for 211 
C4H activity. A recent study describes several novel highly-specific TAL enzymes that are functional and produce 212 
high levels of p-coumaric acid in E. coli, Lactococcus lactis, as well as in S. cerevisiae [101]. Alternatively, use of a 213 
promiscuous PAL that can also take up L-tyrosine as a substrate for the production of the flavanone naringenin has 214 
been reported in E. coli [102, 103]. 215 
Flavonoids are by far the most explored group of polyphenols in terms of heterologous production in 216 
microorganisms [104]. De novo biosynthesis of complex flavonoids would require efficient production of the 217 
flavonoid core molecules, flavanones. These compounds are synthesized by CoA-esterification of cinnamates, such 218 
as p-coumaric acid and cinnamic acid, by 4-coumaroyl-CoA ligase (4CL), followed by condensation with three 219 
malonyl-CoA molecules catalyzed by chalcone synthase (CHS) and subsequent ring closure by chalcone isomerase 220 
(CHI). Further chemical modifications of flavanones, such as hydroxylations, methylations, methoxylations, 221 
acylations, and glycosylations, give rise to the vast diversity of flavonoid compounds (Fig. (1)). Flavanones such as 222 
naringenin and pinocembrin were successfully produced in E. coli and S. cerevisiae by co-expression of different 223 
combinations of PAL/TAL, 4CL, CHS, and CHI enzymes (for an overview see [35, 105–107]). Biosynthesis of a 224 
more complex flavanone, eriodictyol, has also been engineered in E. coli by additional expression of a flavonoid 3’-225 
hydroxylase (F3’H) enzyme [108]. Furthermore, by combining 4CL, CHS, CHI, and chalcone reductase (CHR), 226 
liquiritigenin, 7-hydroxyflavanone, and butin were produced from, respectively,  p-coumaric acid, cinnamic acid, 227 
and caffeic acid as precursors in both E. coli and S. cerevisiae [109]. To further broaden the spectrum of 228 
microbially-produced flavonoids, the biosynthesis of flavones [110, 111] and isoflavones [112] from precursors was 229 
achieved through the additional introduction of flavone synthase (FNS) or isoflavone synthase (IFS) genes, 230 
respectively. In another study, isoflavone genistein was produced directly from L-phenylalanine in yeast [107] and 231 
from L-tyrosine in E. coli [113]. Co-expression of the above-mentioned flavanone biosynthetic genes with flavanone 232 
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3-hydroxylase (F3H)- and flavonol synthase (FLS)-coding genes yielded the flavonols, kaempferol from L-tyrosine 233 
and galangin from L-phenylalanine [114]. Similarly, production of the flavonol fisetin from L-tyrosine has been 234 
recently established in E. coli by combining the liquiritigenin biosynthesis genes with the genes coding for F3H, 235 
FLS, and F3’H [115]. By combining F3H, dihydroflavonol reductase (DFR) and leucocyanidin reductase (LAR), the 236 
production of flavan-3-ols  (+)-catechin and (+)-afzelechin was achieved from caffeic acid and p-coumaric acid, 237 
respectively [116]. Lastly, flavanones have also been converted to anthocyanins in a four-step pathway involving 238 
F3H, DFR, anthocyanidin synthase (ANS), and anthocyanidin 3-O-glucosyltransferase (3GT) [117, 118]. 239 
As mentioned above, flavonoids can be further modified by various decorating enzymes. Such modifications not 240 
only alter chemical properties and improve stability, but sometimes also grants the compounds novel biological 241 
activities [119, 120]. Thus, modified flavonoids might present additional commercial interest. The most common 242 
modification of plant flavonoids is glycosylation, often occurring at least at one position [120]. Multiple studies 243 
addressed the issues of glucosylation of flavonols [121, 122], flavones [123, 124], flavanones [125], and isoflavones 244 
[122, 126, 127]. Addition of other sugar moieties has been also successfully attempted, including rhamnosylation 245 
[121, 128, 129], xylosylation [130, 131], and galactosylation [132]. Lastly, biosynthesis of quercetin 3-O-N-246 
acetylglucosamine has been reported as well [133]. 247 
Methylation is another common modification, and there have been several studies aiming at microbial biosynthesis 248 
of methylated flavonoids. One such example is the work of Kim et al, where E. coli strains for the production of 249 
ponciretin (4’-O-methylnaringenin) and sakuranetin (7-O-methylnaringenin) were constructed [134]. Other 250 
examples refer to the construction of strains producing the medically-important flavanonol 7-O-methyl 251 
aromadendrin from p-coumaric acid [135] and the flavonol genkwanin (7-O-methyl apigenin) from L-tyrosine. 252 
Compared to flavonoids, microbial production of stilbenes is somewhat less of a hot topic. Nevertheless, numerous 253 
health benefits attributed to this group of polyphenols did stimulate research efforts to produce them heterologously 254 
in microorganisms for various applications in pharmaceutical and food industries. Similarly to flavonoids, stilbenes 255 
are produced via decarboxylative condensation of three malonyl-CoA molecules with the CoA-activated 256 
hydroxycinnamates through the action of stilbene synthase (STS) (Fig. (1)). Original attempts to establish microbial 257 
production of stilbene resveratrol were mainly done by the co-expression of the 4cl and the sts genes , and have been 258 
accomplished in both S. cerevisiae and E. coli [136–140]. A more systematic approach comprising the use of two 259 
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different production strains, two promoter systems, screening of a sts gene library, and fine-tuning of gene 260 
expression levels further improved the production of resveratrol from p-coumaric in E. coli [141].  The engineered 261 
strain E. coli BW27784 expressing the 4cl genefrom Arabidopsis thaliana and the sts gene from Vitis vinifera 262 
organized in a bi-cistronic operon on a high-copy number plasmid, accumulated the impressive amount of 2.4 g/L 263 
resveratrol after the addition of a fatty acid biosynthesis inhibitor to improve precursor availability.  Research efforts 264 
to bypass the use of the expensive precursor p-coumaric acid by supplying external L-phenylalanine or L-tyrosine 265 
resulted in consistently low titers of resveratrol [104, 107, 142, 143]. However, extensive strain optimization 266 
through i) increase of the availability of L-phenylalanine and malonyl-CoA, ii) integration of the resveratrol 267 
biosynthetic pathway in the genome and iii) introduction of a resveratrol exporter resulted in a S. cerevisiae strain 268 
capable of producing 4 g/L of resveratrol from glucose in a fed-batch fermentation [95].  More recently, resveratrol 269 
was also produced through de novo biosynthesis from both glucose and ethanol via the L-tyrosine intermediate at 270 
approximately 0.5g/L [144]. Biosynthesis of pinosylvin from L-phenylalanine has been also reported [145, 146]. 271 
Several other studies focused on the production of methylated resveratrol derivatives, such as the mono-methylated 272 
pinostilbene and the di-methylated pterostilbene, which are equally or sometimes even considerably more bioactive 273 
than resveratrol [147]. Production of both pinostilbene and pterostilbene from p-coumaric acid was achieved by 274 
additional expression of stilbene O-methyltransferases (OMTs) genes from various sources in both S. cerevisiae and 275 
E. coli [148, 149]. Furthermore, another study has reported production of the unnatural stilbene methyl ethers by the 276 
expression of Oryza sativa OsOMT1 in E. coli [145].  277 
The ever-increasing knowledge of specific pathways and the discovery of novel enzymes have contributed to the 278 
microbial production of difficult-to-synthesize polyphenols, such as certain phenolic acids or coumarins, whose 279 
biosynthesis involves production of cytochrome P450 enzymes or O-methyl-transferases.  Identification of several 280 
bacteria-compatible hydroxylases that can replace p-coumarate 3-hydroxylase (C3H, a P450 enzyme) has made it 281 
possible to engineer artificial pathways for the biosynthesis of caffeic and ferulic acids from L-tyrosine or p-282 
coumaric acid [91, 142, 150–152]. Maximal concentrations of 767 mg/L of caffeic acid and 196 mg/L ferulic acid 283 
were produced de novo by L-tyrosine overproducer strains of E. coli expressing, respectively, TAL and 4-284 
hydroxyphenylacetate 3-hydroxylase [150] or TAL, C3H, and a caffeic acid methyltransferase (COM) [152]. 285 
Production of plant-specific coumarins in bacteria has been also described [153]. At the first stage, E. coli strains 286 
were engineered to convert the phenylpropanoid acid precursors, p-coumaric acid and ferulic acid, into the simple 287 
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coumarins, umbelliferone (4.3 mg/L) and scopoletin (27.8 mg/L), respectively. Furthermore, these two coumarins 288 
were later-on produced de novo without the addition of any precursor after assembling the complete artificial 289 
biosynthetic pathway in E. coli. This pioneering study set the foundation for microbial production of more diverse 290 
coumarin molecules. Coumarins are components of various polymers [154] and were also demonstrated to have 291 
analgesic and anti-inflammatory properties [155], thus their production in microbial cell factories could also be of a 292 
commercial interest. 293 
Although the use of S. cerevisiae and E. coli presents multiple advantages, other microorganisms might be more 294 
suitable for production of polyphenolic compounds, for example due to higher end-product tolerance or a broader 295 
range of growth substrates. One of the first attempts of using a non-conventional host for the flavonoid production 296 
was done in Streptomyces venezuelae, where the flavanones naringenin and pinocembrin, as well as the stilbenes 297 
resveratrol and pinosylvin were produced from, p-coumaric acid and cinnamic acid, respectively [156]. The same 298 
organism was later on engineered for the biosynthesis of kaempferol and galangin by the co-expression of the f3h 299 
gene from Citrus siensis and the fls gene from Citrus unshius and feeding with naringenin or pinocembrin, 300 
respectively [157]. A more recent study has demonstrated the feasibility of polyphenol production in 301 
Corynebacterium glutamicum, a soil bacterium that is used for amino acid production on industrial scale. 302 
Kallscheuer et al, were able to engineer this bacterium to produce resveratrol and naringenin directly from glucose 303 
with yields comparable to those observed in E. coli [158]. Moreover, C. glutamicum was further engineered for the 304 
production of resveratrol from 4-hydroxybenzoic acid (HBA) by reversal of a β-oxidative phenylpropanoid 305 
degradation pathway [159]. This allows having polyphenol production independent from the aromatic amino acid 306 
biosynthesis. The most “exotic” case was a study where the edible macrofungus Tremella fuciformis Berk. (silver 307 
ear or white jelly mushroom, division Basidiomycota) was genetically modified for the biosynthesis of resveratrol 308 
from p-coumaric acid with yields of 0.8-0.9 μg/g of dry weight after 7 days of cultivation [160]. 309 
Strategies for improving production of polyphenolic compounds in microorganisms 310 
Metabolic engineering is the introduction of targeted adjustments to cellular metabolic processes aiming at 311 
improving production of a certain substance. This is often achieved with a set of genetic manipulations that leads to 312 
alterations within various regulatory, enzymatic, and transport functions of the cell [161, 162]. Metabolic 313 
engineering is particularly important for optimization of heterologous pathways, as introduction of such pathways 314 
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often leads to flux imbalance, not only within the pathway, but also often within the global cellular metabolism. This 315 
occurs because the host generally lacks the regulatory machinery required for efficient and balanced operation of the 316 
pathway, and also to prevent over- or under-production of enzymes, leading to metabolic burden on the host at the 317 
cost of productivity of the compound of interest, as well as accumulation of potentially toxic intermediates [163]. 318 
One of the key targets for metabolic pathway engineering is the improvement of precursor supply. The most notable 319 
strategies for that are summarized in Table 4. Numerous studies dealing with polyphenol production have concluded 320 
that increasing the intracellular pool of malonyl-CoA is the key requirement for enhancing the flavonoid and 321 
stilbene production [112, 164, 165]. The most common strategies for that are a) the overexpression of an acetyl-CoA 322 
carboxylase (ACC)-coding gene that converts acetyl-CoA into malonyl-CoA and b) the inhibition of fatty acid 323 
biosynthesis by addition of the antibiotic cerulenin [35, 146, 166, 167]. Further improvement could be achieved 324 
through the fine-tuning of the acetate assimilation via the overexpression of acetyl-CoA synthetase gene and the 325 
deletion of the acetate-utilizing pathways, which overall resulted in a 16.3-fold increase of intracellular malonyl-326 
CoA concentration [108, 166]. Other alternatives include the introduction of a malonate catabolic pathway [168, 327 
169], the overexpression of  the 3-ketoacyl-ACP synthase genes fabH and fabF [166, 170], and the conditional 328 
down-regulation of fatty acid biosynthesis with CRISPR interference (CRISPRi) [171]. Several other studies in E. 329 
coli have taken a more global approach, combining computational predictions and experimental validations [165, 330 
172, 173]. The utilized genome-scale models predicted a set of genetic interventions, mainly aiming to up-regulate 331 
some of the glycolytic reactions and down-regulate the tricarboxylic acid (TCA) cycle that cooperatively drive the 332 
carbon flux towards malonyl-CoA, while at the same time preventing the formation of byproducts. These 333 
interventions were experimentally validated using a lab-scale fermenter, and the introduced genetic modifications 334 
resulted in a significantly improved production of naringenin (474 mg/L, [172]) and resveratrol (1600 mg/L, [173]).  335 
Other substrates/co-factors critical for the biosynthesis of flavonoids are the UDP-glucose and NADPH [117, 169, 336 
174]. The former one is the donor of the glucosyl group in the anthocyanin biosynthesis as well as in other flavonoid 337 
biosynthetic routes, whereas the latter one is required for the biosynthesis of leucoanthocyanidins, 5-338 
deoxyflavanones, and (+)-catechins (Fig. (1)). Engineering of UDP-glucose levels through a combination of 339 
overexpressing genes of the UTP biosynthetic pathway, supplementation with orotic acid, and deletion of several 340 
endogenous UDP-glucose-utilizing genes resulted in the significantly improved anthocyanin production from 341 
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flavan-3-ols precursors in an E. coli strain expressing ANS- and 3GT-coding genes [169]. Recently, a follow-up 342 
study has reported that overexpression of the ycjU gene, which catalyzes the conversion of β anomer of glucose-6-343 
phosphate into glucose-1-phosphate, further increases the UDP-glucose pools, and consequently anthocyanin 344 
production [118]. With regard to improving the intracellular NADPH availability, a stoichiometry-based model was 345 
deployed to identify a set of potential gene knock-out combinations in E. coli. Upon validation of the candidates, the 346 
combined inactivation  of phosphoglucose isomerase, phosphoenolpyruvate carboxylase, and phospholipase 347 
activities resulted in a 4-fold increase of leucoanthocyanidin production and a 2-fold increase of (+)-catechin 348 
production, as compared to the wild-type background [174].  349 
Another challenge to the current metabolic engineering strategies is the use of media supplemented with expensive 350 
precursors (e.g. p-coumaric acid or naringenin) and, a two step-fermentation process (biomass/protein production 351 
and polyphenol synthesis) that becomes a disadvantage when the process scale-up is considered. Partly, this issue 352 
comes from the fact that biosynthetic pathways for complex polyphenols such as flavonols and anthocyanins consist 353 
of six or more genes. Overexpression of such high number of genes would first of all cause a large metabolic burden 354 
to the cell. This problem has already been partly addressed by using a co-culture strategy [175]. With this approach, 355 
Jones et al. have split the (+)-afzelechin biosynthetic pathway between the two co-incubated strains: the first one 356 
was expressing the malonyl-CoA-dependent part (from p-coumaric acid to naringenin), whereas the second strain 357 
was expressing the NADPH-dependent downstream part (from naringenin to (+)-afzelechin). Another advantage of 358 
the co-cultivation system is that the two strains could be independently engineered for enhanced precursor supply 359 
(e.g. malonyl-CoA or NADPH) without significantly impacting the cellular metabolism. One of the major 360 
parameters that need to be considered and optimized in such experiments is strain compatibility. The selected strains 361 
must have similar growth kinetics to avoid out competition of one, which can lead to an imbalance in the pathway. 362 
The authors addressed this issue by introducing the plasmids containing the biosynthetic genes into multiple 363 
background strains and selecting the most fitting combination. Equal growth could also potentially be ensured by 364 
introducing two different auxotrophies in the production strains in a way that would make them dependent on one 365 
another. Furthermore, production of compounds that are toxic to other members of the consortium must be avoided 366 
and efficient transfer of pathway metabolites from one partner to another must be ensured. The second issue is that 367 
expression of this many genes could be challenging due to lack of compatible sets of overexpression vectors for 368 
many industrially-relevant microorganisms. This, however, is not an issue for E. coli where the complete 369 
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biosynthetic pathway for the flavonol fisetin from L-tyrosine consisting of seven genes has been established using 370 
the DUET vector system, in which genes were expressed in pairs utilizing four different expression vectors [115]. 371 
There is also an interesting solution in S. cerevisiae that involves the use of a polyprotein system allowing co-372 
transcription of multiple coding sequences from a single promoter. The system has already been used for the 373 
production of 2-hydroxynaringenin-C-glucoside [176]. Furthermore, in order to allow complete de novo 374 
biosynthesis, both bacterial and yeast strains have been engineered for the production of flavonoids and stilbenes 375 
from inexpensive substrates, such as glucose, by introducing heterologous genes coding for various polyphenol 376 
biosynthesis pathways into L-tyrosine- or L-phenylalanine-overproducing strains [168, 177–179].  377 
Microbial production of polyphenols is often challenged by toxicity of the end-product and/or of its biosynthetic 378 
intermediates, as well as by the formation of inclusion bodies resulting from protein overproduction. The former 379 
issue is related to anti-microbial properties of polyphenols, which could become an issue particularly if the produced 380 
molecules accumulate intracellularly at high concentrations. One possible approach to resolve this is to co-express 381 
an exporter protein that would extrude the produced polyphenols into the culture medium [95]. Another approach is 382 
to use adaptive laboratory evolution (ALE), which consists of continuous cultivation of the producer microorganism 383 
while subjecting it to increasing concentrations of the polyphenols. This process generally results in accumulation of 384 
mutations that would increase tolerance of the producer strain towards the target compound [180, 181]. Furthermore, 385 
cytotoxic effect of the biosynthetic intermediates could be avoided by balancing expression levels of individual 386 
genes within the given pathway [168, 182]. The second issue arises from the necessity for some enzymes to form 387 
complexes in order to ensure high local substrate concentrations, in particularly if a reaction is unfavorable [82]. 388 
However, this could also be of an advantage even if the coupling is unnatural, as it would ensure efficient flux from 389 
one step of a pathway to another. There are multiple ways of ensure close proximity of biosynthetic enzymes and 390 
their intermediates, including intracellular compartmentalization [82], use of synthetic scaffolds [183], and 391 
construction of translational fusions. The latter approach has been used multiple times for engineering of polyphenol 392 
production, including construction of the 4CL::STS fusion for enhancing resveratrol production [137], construction 393 
of CHS::CHR fusion for increasing liquiritigenin production [115], and use of P450::CPR to allow functional 394 
expression of P450 enzymes in bacteria [108, 112, 115]. 395 
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A recent report has drawn the attention to the interference of native aromatic acid degradation pathways with the 396 
production of polyphenols [135]. Detailed analysis of E. coli strains producing 7-O-methyl aromadendrin showed 397 
that the final concentration of this flavanonol did not correspond to the consumption of p-coumaric acid, indicating 398 
possible degradation of the precursor via an unknown pathway [184]. S. cerevisiae has been also reported to have  399 
more than one enzyme catalyzing decarboxylation of trans-cinnamic acid and p-coumaric acid, a reaction which 400 
could also potentially reduce production of polyphenols [185]. A similar situation was observed in C. glutamicum 401 
where a phenylpropanoid degradation gene cluster had to be deleted prior to engineering of this bacterium for 402 
stilbene and flavonoid production [158, 186].Therefore, possible presence of such enzymes and pathways needs to 403 
be accounted for, in particular prior to exploration of a new production host. 404 
Another interesting recent development is the emergence of combinatorial gene expression techniques that appear to 405 
be promising approaches to address the challenge of improving titers and productivity efficiency [163, 187]. 406 
However, their successful application is highly dependent on the availability of high-throughput methods for strain 407 
screening [188]. Recently, two flavonoid biosensors were constructed consisting of the reporter gene coding for the 408 
fluorescent protein placed under control of the flavonoid-responsive transcriptional regulator [189]. The 409 
transcriptional regulators FdeR from Herbaspirillum seropedicae SmR1 was used to generate a biosensor to detect 410 
naringenin, whereas QdoR from B. subtilis was used to detect quercetin and kaempferol. The QdoR-based biosensor 411 
was highly efficient in detecting kaempferol production in vivo at the single cell level while using fluorescence-412 
activated cell sorting (FACS). The developed biosensors could be subsequently used for identification of novel 413 
genes involved in polyphenol biosynthetic pathways [189]. Another biosensor has been developed based on the B. 414 
subtilis transcription factor FapR that is responsive to malonyl-CoA [190]. This sensor could therefore be used for 415 
selection of candidates with increased intracellular concentrations of malonyl-CoA. Liu et al. [191] have used the 416 
same transcription factor in order to develop a negative feedback regulatory circuit. The circuit relies on a malonyl-417 
CoA-based sensor-actuator system that controls expression of the acc gene, and in this way alleviates the toxic 418 
effects of high intracellular concentration of the enzyme. The circuit was proven to be efficient in regulating the 419 
fatty acid biosynthetic pathway and increasing fatty acid titer and productivity [191]. Application of such system for 420 
microbial production of polyphenols should allow balancing the engineered pathways and subsequently improve the 421 
production efficiency. Other approaches and techniques that have been successfully utilized for fine-tuning gene 422 
expression for the needs of metabolic engineering were thoroughly reviewed in [192]. Furthermore, a new screening 423 
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technique based on high-performance thin-layer chromatography (HPTLC) has been developed for the discovery of 424 
flavonoid-modifying enzymes [193]. The authors claim that this metagenome extract thin-layer chromatography 425 
analysis (META) allows rapid detection of glycosyltransferases and other flavonoid-decorating enzymes, as well as 426 
that the system is highly sensitive, being able to detect of as little as 4 ng of a modified molecule. 427 
Conclusion 428 
There has been a substantial progress in the field of microbial production of polyphenols. The recent advances in 429 
genome editing, combined with novel engineering tools, now allow the expression of multiple genes coding for 430 
enzymes forming complex biosynthetic polyphenol pathways not only in model organisms such E. coli and S. 431 
cerevisiae, but also in more novel productions hosts, such as C. glutamicum, L. lactis, and Streptomyces venezuelae. 432 
Nonetheless, in many cases the production efficiency using microbial hosts remains inferior as compared to 433 
extraction from plants. However, constant advances of synthetic biology tools combined with future metabolic 434 
engineering efforts will further facilitate the development of more economically-favorable production processes. 435 
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Table 1. Health-beneficial properties of the major groups of polyphenols. 1024 
Polyphenol Applications: health-promoting or biotechnological 
Phenolic acids 
Examples: 
Gallic acid 
Caffeic acid 
Ferulic acid 
Chlorogenic acid 
 
Cancer: Chemopreventive activity, as well as protection against side effects of 
chemotherapy [194, 195]. 
CVD and Diabetes: Prevent oxidation of low-density lipoprotein (LDL)-cholesterol 
and effective in the treatment of hypercholesterolemia and type 2 diabetes [196–198].  
Neurodegenerative diseases: Potential as agents for the treatment of Alzheimer’s 
disease [199]. 
Others: Anti-allergic; anti-microbial; antioxidant and immunomodulatory activities.  
Di- and tri-caffeic/quinic acids have antiretroviral activity [200–204]. 
Anthocyanins 
Examples: 
Cyanidin 
Pelargonidin 
Delphinidin 
Rosinidin 
Cancer: Inhibit initiation and progression stages of tumor development; reduce effect 
of inflammation on promotion of tumorogenesis; suppress angiogenesis; minimize 
cancer-induced DNA damage [205–207]. 
CVD and Diabetes: Improve vascular health; protect against cardiovascular diseases; 
anti-obesity effects through improvement of adipocyte function; may contribute to 
prevention of the metabolic syndrome; potential anti-diabetic activity [64, 205, 208–
210]. 
Neurodegenerative diseases: Protection against brain ageing and decline in cognitive 
performance in animal models [205, 211, 212]. 
Others: Reduce inflammatory biomarkers; bacteriostatic against some gut pathogenic 
bacteria; food colorants [205, 208, 213, 214]. 
Flavonols  
Examples: 
Quercetin 
Kaempferol 
Myricitin 
Fisetin 
Morin 
Cancer: Protective effects against pancreatic, breast, cervical, prostate, uterine, 
urinary tract cancers, and leukemia [49, 215–217]. 
CVD and Diabetes: Confer cardioprotection and improve the levels of risk factors 
for cardiovascular disease [218, 219].   
Neurodegenerative diseases: Neuroprotective activity in experimental focal 
ischemia and models of neurodegeneration; cognition-enhancing; reduce the risk of 
Alzheimer's disease [220–222]. 
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Rutin Inflammation: Anti-inflammatory [223]. 
Others: Anticonvulsant, antioxidants, memory enhancement [203, 224, 225]. 
Flavanols 
Examples: 
Catechins 
Epigallocatechin 
Thearubigins 
Mesquitol 
 
Cancer: Inhibition of tumorigenesis in different organs of animals [205, 226].  
CVD and Diabetes: Cardioprotective effect by reverting of endothelial dysfunctions; 
decreasing inflammatory biomarkers, and providing antioxidant and antiplatelet 
effects. Also have beneficial effects on blood pressure, blood glucose level, and lipid 
parameters [227–230]. 
Neurodegenerative diseases: Neuroprotective/neuroregenerative effects as 
modulators of intracellular neuronal signaling and metabolism, cell survival/death 
genes, and mitochondrial function [212, 231]. 
Hydrolyzable tannins  
Examples: 
Grandinin 
Casuarictin 
Punicalagin 
Vescalagin 
Cancer: Anti-tumor, anti-proliferative and anti-mutagenic effects [232, 233]. 
CVD and Diabetes: Anti-diabetic; anti-atherogenic; anti-thrombotic [234, 235]. 
Others: Anti-inflammatory, anti-bacterial, and anti-mycotic properties. Ellagitannins 
and gallotannins may also affect the life of foodstuff due to their antioxidant 
properties and/or antimicrobial activity [236, 237]. 
Isoflavones 
Examples: 
Genistein 
Daidzein 
Curcumin 
Glycetin 
Cancer: Inhibition of cell proliferation [47, 238, 239]. 
CVD and Diabetes: Anti-platelet effects [240, 241]. 
Others: Neuroprotective agents; improve cognitive functions and alleviate 
menopause symptom in females; anti-thyroid activity [242–244]. 
Proanthocyanidins 
(Condensed tannins) 
Examples: 
Epichatechin trimer 
Selligueain A 
Procyanidin B3 
Cancer: Reduce the incidence and progression of cancer (particularly of prostate 
cancer) [245, 246]. 
CVD and Diabetes: Reduction of  CVD incidence due to their antioxidant activity; 
inhibition of LDL oxidation; vasodilating properties; anti-platelet activity and 
protection against ischemia-reperfusion injury [245, 247, 248]. 
Others: Proanthocyanidin-rich extracts inhibit viral adhesion and infectivity of the A 
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and B influenza viruses, as well as suppress urinary and Helicobacter  pylori 
infections, procyanidin B3 has been described as a hair-growth stimulant, selligueain 
A is a natural sweetener [245, 249–251]. 
Lignans 
Examples: 
Secoisolariciresinol 
Pinoresinol 
Podophyllotoxin 
Steganacin 
Cancer: Anti-carcinogenic effects on multiple types of cancer [252–254]. 
CVD and Diabetes: Associated with a decreased risk of cardiovascular diseases, 
hypoglycemic properties [255, 256]. 
Others: Inhibition of H. pylori motility and steroid hormone metabolism, anti-viral 
activities [252, 254, 257]. 
Stilbenoids 
Examples: 
Resveratrol 
Pterostilbene 
Pinosylvin 
Piceid 
Cancer: in vitro as well as in vivo chemopreventive and chemotherapeutic activities, 
in all three stages of carcinogenesis (initiation, promotion, and progression) [46, 258]. 
CVD and Diabetes: Improve insulin sensitivity, mimics calorie restriction, lower 
plasma lipoproteins and cholesterol, prevent cell damage induced by oxidative stress 
and ischemia [259–262]. 
Others: anti-aging and anti-inflammatory
  
activities, relives endotoxemia-associated 
adrenocortical insufficiency, confer protection against intestinal barrier dysfunction, 
modulate gut microbiota by favoring increase in lactic acid bacteria counts [46, 214, 
263–266]. 
CVD – cardiovascular diseases 1025 
  1026 
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Table 2. Examples of polyphenol-containing products accessible to consumers. 1027 
Type of polyphenol Production method Examples of products on the market (supplier) 
Phenolic acids 
(Hydroxycinnamic and 
hydroxybenzoic acids) 
 Extraction from plants  GCA™-Green Coffee Antioxidant 
(Applied Food Sciences) 
Anthocyanins 
 
 Extraction from plants 
 
 Extraction from 
bilberry  
 
 Extraction from 
bilberry  
 Freeze Dried Polyphenol Fruitbasket (BerryPharma) 
 
 Mirtoselect® and Myrtocyan® (Indena®) 
 
 
 NutriPhy® Bilberry 100 (Chr. Hansen A/S) 
Flavonols  
(Quercetin/kaempferol/ 
myricetin) 
 Chemical synthesis 
 
 Extraction from plants 
 Quercitin complex (Solgar) 
 
 Bayberry Bark Extract Myricetin (Cactus Botanics) 
Flavanols  
(Catechins) 
 
 Extraction from plants 
 
 
 Extraction from plants 
 
 Extraction from plants 
 Green Tea Catechins, Decaf - Camellia sinensis, 
(Amax)  
 
 NutraSource, AssuriTEA Green, (Kemin Health) 
 
 Theaflavin Black Tea Extract (Applied Food Sciences) 
Hydrolyzable tannins  
(Casuarictin) 
 Extraction from plants  PomActivTM Pomegranate Extract (Cyvex Nutrition) 
Isoflavones 
(Genistein) 
 Extraction from soy  geniVida® (DSM) 
Proanthocyanidins 
(Epichatechin trimer) 
 Extraction from plants 
 
 Pine Bark 95% Proanthocyanidins (Cactus Botanics) 
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 Extraction from plants  ENOVITA® - grape seed extract and proanthocyanidin 
A2 phytosome (Indena) 
Lignans 
(Secoisolariciresinol) 
 Extraction from plants 
 
 Extraction from plants 
 Flaxseed Lignans (Cactus Botanics) 
 
 ActiFlax (Marco Hi-Tech) 
Stilbenes 
(Resveratrol) 
 Extraction from plants 
 
 Chemical synthesis 
 
 Microbial production 
 Rexatrol® - resveratrol phytosome® (Indena) 
 
 ResVida (DSM) 
 
 EveResveratrolTM (Evolva) 
 1028 
  1029 
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Table 3. Production of polyphenolic compounds in microbial hosts. 1030 
Compound Precursor Host Reference Highest titer 
Phenolic acids     
p-coumaric acid L-Phenylalanine S. cerevisiae [100] ~ 7.2 mg/L 
L-Tyrosine S. cerevisiae [179] 1.93 g/L 
L-Tyrosine E. coli [101, 152] 1.6 mmol/g CDW 
S. cerevisiae [101] 133 μmol/g CDW 
L. lactis 43 μmol/g CDW 
Caffeic acid L-Tyrosine E. coli [151, 152] 150 mg/L 
Glucose E. coli [91, 150] 767 mg/L 
Ferulic acid L-Tyrosine E. coli [152] 196 mg/L 
     
Flavanones     
Naringenin L-Tyrosine E. coli [102, 103, 
164] 
57 mg/L 
L-Phenylalanine S. cerevisiae [107] 8.9 mg/L 
p-Coumaric acid E. coli [172] 474 mg/L 
Glucose E. coli [178] 84 mg/L 
Glucose C. glutamicum [158] 32 mg/L 
Glucose S. cerevisiae [177] 113 mg/L 
p-Coumaric acid St. venezuelae [156] 4 mg/L 
Pinocembrin L-Phenylalanine E. coli [102, 164] 58 mg/L 
Glucose E. coli [168] 40 mg/L 
Cinnamic acid St. venezuelae [156] 6 mg/L 
Eriodictyol L-Tyrosine E. coli [108] 43 mg/L 
Liquiritigenin p-Coumaric acid E. coli [109] 17 mg/L 
S. cerevisiae 14 mg/L 
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7-hydroxyflavanone Cinnamic acid E. coli 1.9 mg/L 
S. cerevisiae 0.9 mg/L 
Butin Caffeic acid E. coli 4.2 mg/L 
S. cerevisiae 2.5 mg/L 
Sakuranetin L-Tyrosine E. coli [134] 40 mg/L 
Ponciretin L-Tyrosine E. coli [134] 43 mg/L 
     
Flavones     
Chrysin Cinnamic acid S. cerevisiae [110] 0.9 mg/L 
 L-Phenylalanine E. coli [114] 9 mg/L 
Apigenin p-Coumaric acid S. cerevisiae [110] 0.4 mg/L 
L-Tyrosine E. coli [111, 114] 30 mg/L 
Genkwanin L-Tyrosine E. coli [111] 41 mg/L 
Luteolin Caffeic acid S. cerevisiae [110] 1.6 mg/L 
     
Isoflavones     
Genistein Naringenin E. coli [112] 10 mg/g CDW 
 L-Phenylalanine S. cerevisiae [107] 0.1 mg/L 
Daidzein Liquiritigenin E. coli [112] 18 mg/g CDW 
     
Flavonols     
Kaempferol L-Tyrosine E. coli [114] 15 mg/L 
Naringenin St. venezuelae [157] 0.2 mg/L 
L-Phenylalanine S. cerevisiae [107] 1.3 mg/L 
Galangin L-Phenylalanine E. coli [114] 1.1 mg/L 
Pinocembrin St. venezuelae [157] 1.0 mg/L 
Fisetin L-Tyrosine E. coli [115] 0.3 mg/L 
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Quercetin p-Coumaric acid S. cerevisiae [107] 0.26 mg/L 
7-O-methyl aromadendrin p-Coumaric acid E. coli [135] 3 mg/L 
     
Flavan-3-ol     
(+)-catechin Caffeic acid E. coli [116] 0.09 mg/L 
(+)-afzelechin p-Coumaric acid E. coli [116] 0.04 mg/L 
     
Anthocyanins     
Pelargonidin 3-O-glucoside Naringenin E. coli [267] 6 μg/L 
Cyanidin 3-O-glucoside Eriodictyol E. coli [267] 6 μg/L 
(+)-catechin E. coli [118] 350 mg/L 
     
Stilbenes     
Resveratrol p-Coumaric acid S. cerevisiae [136–138, 
140] 
391 mg/L 
Glucose S. cerevisiae [144] 531 mg/L 
Glucose S. cerevisiae [95] 4 g/L 
p-Coumaric acid E. coli [139, 141, 
173] 
1600 mg/L 
Glucose C. glutamicum [158] 59 mg/L 
p-Coumaric acid St. venezuelae [156] 0.4 mg/L 
p-Coumaric acid T. fuciformis [160] 0.8 μg/g CDW 
Pinosylvin L-Phenylalanine E. coli [145, 146] 91 mg/L 
Glycerol E. coli [171] 47 mg/L 
L-Phenylalanine St. venezuelae [156] 0.6 mg/L 
Pterostilbene p-Coumaric acid E. coli [148] 50 mg/L 
Pinostilbene p-Coumaric acid E. coli [149] 34 mg/L 
CDW – cell dry weight 1031 
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Table 4: Metabolic engineering strategies used for improving precursor supply for polyphenol biosynthesis 1032 
Target Approach Host organism References 
Malonyl-CoA pool 
 Addition of cerulenin E. coli [146, 170, 
173, 178] 
 C. glutamicum [158] 
 O/E of ACC E. coli [108, 166, 
172] 
 S. cerevisiae [144] 
 O/E of acetyl-CoA synthase E. coli [108, 166] 
 K/O of acetate kinase  E. coli [108, 166] 
 O/E of fabF and fabE E. coli [166, 170] 
 Expression of MatB and MatC 
from Rhizobium trifolii 
E. coli [168, 169] 
 Repression of fabD E. coli [171] 
 Up-regulation of glycolysis and 
down-regulation of the TCA cycle 
E. coli [165, 172, 
173] 
    
UDP-glucose availability 
 O/E of pgm, galU, ndk E. coli [169] 
 K/O of galE and galT E. coli [169] 
 O/E of ycjU E. coli [118] 
    
NADPH availability 
 Deletion of pgi, ppc, and pldA E. coli [174] 
    
Aromatic amino acid availability    
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 Modifications of the shikimate 
pathway 
E. coli [168] 
 S. cerevisiae [177, 179] 
 Reducing flux through the Ehrlich 
pathway 
S. cerevisiae [177] 
O/E – overexpression, K/O – knock-out, TCA cycle – tricarboxylic acid cycle 1033 
 1034 
Isoflavones 
Isoflavonoids 
Cinnamic acid p-Coumaric acid 
L-Phenylalanine 
p-Coumaroyl-CoA 
Chalcone 
TAL 
Flavanone 
FLAVONOIDS 
LIGNIN 
LIGNANS 
Leucoanthocyanidins 
(Flavan-3,4-diols) 
Anthocyanins 
F3H 
ANS 
3GT 
 
AAT 
AMT 
DFR 
PHENOLIC ACIDS & 
Derivatives  
PHENYLPROPENES 
COUMARINS 
AURONES 
Dihydroflavonol 
ANR 
Amino acid metabolism 
C3H 
PAL 
C4H 
Other phenylpropanoids 
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Figure 1. Plant polyphenols and their biosynthetic routes. Names of enzymes: 3GT, anthocyanidin 3-O-
glycosyltransferase; 4CL, 4-coumaroyl-CoA ligase; AAT, anthocyanin acyltransferase; AMT, anthocyanin 
methyltransferase; ANR, anthocyanidin reductase; ANS, anthocyanidin synthase (leucoanthocyanidin 
dioxygenase); C3H, p-coumarate 3-hydroxylase; C4H, cinnamate 4-hydroxylase; CHI, chalcone isomerase; 
CHS, chalcone synthase; CUS, curcuminoid synthase; DFR, dihydroflavonol 4-reductase; F3H, flavanone 3-
hydroxylase; FLS, flavonol synthase; FNS, flavone synthase; IFS,  isoflavone synthase; LAR, 
leucoanthocyanidin reductase;OMT, 3-O-methyltransferase; PAL, phenylalanine ammonia-lyase; STS, 
stilbene synthase; TAL, tyrosine ammonia-lyase ([1–3]). 
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